Kevin P. Bliden
Kevin P. Bliden publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine, on topics such as Antiplatelet Therapy and Cardiovascular Diseases, Venous Thromboembolism Diagnosis and Management and Atrial Fibrillation Management and Outcomes.
- World rank
- #404,783 of 7,710,434 ranked researchers
- Rank in United States
- #143,502 of 1,627,098
- Works
- 338
- Citations
- 15k
- Citations per work
- 43.6
What does Kevin P. Bliden research?
Kevin P. Bliden's work is mostly in Medicine (75%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences25374.9%
- Medicine25374.9%
- Everything else8525.1%
- 1Cardiology and Cardiovascular Medicine39% of their works
- 2Surgery14% of their works
- 3Internal Medicine8% of their works
- 4Hematology6% of their works
- 5Pharmacology4% of their works
- 6Infectious Diseases4% of their works
Research topics
- Antiplatelet Therapy and Cardiovascular Diseases
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research
- Coronary Interventions and Diagnostics
- Lipoproteins and Cardiovascular Health
- Platelet Disorders and Treatments
- Inflammatory mediators and NSAID effects
Which keywords describe Kevin P. Bliden's research?
The keywords of their largest research topics: Percutaneous Coronary Intervention, Aspirin, Clopidogrel, Guidelines, Antithrombotic Therapy, Venous Thromboembolism, Inflammation and Anticoagulant Therapy.
- Cancer
- Platelets
- Cholesterol-lowering
- Coronary Stents
- Acute Coronary Syndromes
- Anticoagulant Therapy
- Venous Thromboembolism
- Guidelines
- Aspirin
- Percutaneous Coronary Intervention
- Clopidogrel
- Antithrombotic Therapy
- Inflammation
- Atrial Fibrillation
- Myocardial Infarction
- Myocardial Revascularization
- Statins
- Thrombosis
- Cyclooxygenase-2 Inhibitors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Percutaneous Coronary Intervention2372 topics
- Aspirin1871 topic
- Clopidogrel1871 topic
- Guidelines1072 topics
- Antithrombotic Therapy731 topic
- Venous Thromboembolism731 topic
- Inflammation642 topics
- Anticoagulant Therapy551 topic
- Atrial Fibrillation551 topic
- Acute Coronary Syndromes521 topic
- Myocardial Infarction521 topic
- Coronary Stents501 topic
- Myocardial Revascularization501 topic
- Cholesterol-lowering441 topic
- Statins441 topic
- Platelets381 topic
- Thrombosis381 topic
- Cancer261 topic
- Cyclooxygenase-2 Inhibitors261 topic
Where does Kevin P. Bliden work?
Kevin P. Bliden's main affiliation in the publication record is Sinai Hospital, United States.
How many publications and citations does Kevin P. Bliden have?
OpenAlex counts 338 works and 14,748 citations for Kevin P. Bliden, an h-index of 54, ranking #404,783 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kevin P. Bliden. Posts are plain text and can be reported.